Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2)
inhibitor. The SGLT2 class is recognised for cardiorenal benefit alongside
glycaemic control, which keeps demand for the API strong across regulated and
semi-regulated markets. ApiSyn manufactures it in Ahmedabad, India, with
specifications, COA and technical documentation available on request. Related
impurity reference standards can be arranged through SynZeal.
| Chemical Name | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy] phenyl]methyl]phenyl]-D-glucitol |
| Molecular Formula | C23H27CIO7 |
| Molecular Weight | 450.9 |
| CAS Number | 864070-44-0 |